Ben Hirschler

Drugmaker GSK to split after striking Pfizer consumer health deal

Dec 19 2018

LONDON GlaxoSmithKline plans to split into two businesses -- one for prescription drugs and vaccines, the other for over-the-counter products -- after forming a new joint venture with Pfizer's consumer health division. | Video

GSK slides after buying cancer firm Tesaro for hefty $5.1 billion

Dec 03 2018

LONDON GlaxoSmithKline has agreed to buy U.S. cancer specialist Tesaro for $5.1 billion, a costly investment to rebuild the pharmaceuticals business by new Chief Executive Emma Walmsley that unnerved investors. | Video

Unilever swallows GSK's Indian Horlicks business for $3.8 billion

Dec 03 2018

LONDON Unilever is to buy GlaxoSmithKline's Horlicks nutrition business for $3.8 billion, boosting the Anglo-Dutch group's position in India by adding the popular malted drink.

Millions left behind as diabetes drives surge in insulin demand

Nov 20 2018

LONDON A global diabetes epidemic is fuelling record demand for insulin but tens of millions will not get the injections they need unless there is a dramatic improvement in access and affordability, a new study concluded on Wednesday.

Big pharma leaves big gaps: drugmakers urged to do more for poor

Nov 20 2018

LONDON Many of the world's top drugmakers are not doing enough to provide medicines to poor countries, leaving big gaps in access to treatments in crucial disease areas, including cancer, according to a new report on Tuesday.

Boston Scientific builds medical technology with $4.2 billion BTG deal

Nov 20 2018

LONDON U.S. medical device maker Boston Scientific Corp has agreed to buy Britain's BTG Plc for 3.3 billion pounds ($4.24 billion) in cash, adding technology to fight cancer and other serious diseases to its portfolio.

World News